These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38698025)

  • 21. Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin-related amyloidosis-A Swiss reference center experience.
    Loser V; Benkert P; Vicino A; Lim Dubois Ferriere P; Kuntzer T; Pasquier J; Maceski A; Kuhle J; Theaudin M
    J Peripher Nerv Syst; 2023 Mar; 28(1):86-97. PubMed ID: 36471582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ophthalmological involvement in wild-type transthyretin amyloidosis: A multimodal imaging study.
    Frizziero L; Salvalaggio A; Cosmo E; Cipriani A; Midena E; Briani C
    J Peripher Nerv Syst; 2023 Dec; 28(4):586-596. PubMed ID: 37552555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted sequencing of selected functional genes in patients with wild-type transthyretin amyloidosis.
    Moreno-Gázquez I; Pérez-Palacios R; Abengochea-Quílez L; Lahuerta Pueyo C; Roteta Unceta Barrenechea A; Andrés Gracia A; Aibar Arregui MA; Menao Guillén S
    BMC Res Notes; 2023 Oct; 16(1):249. PubMed ID: 37784196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wild-Type Transthyretin Amyloidosis Occurring in the Ligamentum Flavum of the Cervicothoracic Spine.
    George KM; Dowd RS; Nail J; Yu A; Mastroianni M; Wang AY; Arkun K; Patel A; Kryzanski J; Comenzo R; Riesenburger RI
    World Neurosurg; 2020 Oct; 142():e325-e330. PubMed ID: 32652280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers of axonal damage to favor early diagnosis in variant transthyretin amyloidosis (A-ATTRv).
    González-Moreno J; Gragera-Martínez Á; Rodríguez A; Borrachero-Garro C; García-Garrido S; Barceló C; Manovel-Sánchez A; Ribot-Sansó MA; Ibargüen-González L; Gomila R; Muñoz-Beamud F; Losada-López I; Cisneros-Barroso E
    Sci Rep; 2024 Jan; 14(1):581. PubMed ID: 38182630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
    Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
    Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First nationwide survey on systemic wild-type ATTR amyloidosis in Japan.
    Sekijima Y; Yazaki M; Ueda M; Koike H; Yamada M; Ando Y
    Amyloid; 2018 Mar; 25(1):8-10. PubMed ID: 29182024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: Distinct from wild-type transthyretin amyloidosis?
    Razvi Y; Ioannou A; Patel RK; Chacko L; Karia N; Riefolo M; Porcari A; Rauf MU; Starr N; Ganesananthan S; Blakeney I; Kaza N; Filisetti S; Bolhuis RE; Rowczenio D; Gilbertson J; Hutt D; Mahmood S; Lachmann HJ; Wechalekar AD; Kotecha T; Knight DS; Coghlan JG; Petrie A; Whelan CJ; Venneri L; Martinez-Naharro A; Hawkins P; Fontana M; Gillmore JD
    Eur J Heart Fail; 2024 Feb; 26(2):383-393. PubMed ID: 37953725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK.
    Carr AS; Pelayo-Negro AL; Evans MR; Laurà M; Blake J; Stancanelli C; Iodice V; Wechalekar AD; Whelan CJ; Gillmore JD; Hawkins PN; Reilly MM
    J Neurol Neurosurg Psychiatry; 2016 Jun; 87(6):620-7. PubMed ID: 26243339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rate of neuropathic progression in hereditary transthyretin amyloidosis with polyneuropathy and other peripheral neuropathies: a systematic review and meta-analysis.
    Lin X; Yarlas A; Vera-Llonch M; Baranwal N; Biber J; Brown D; Vogt B; Karam C
    BMC Neurol; 2021 Feb; 21(1):70. PubMed ID: 33579211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How your ears can tell what is hidden in your heart: wild-type transthyretin amyloidosis as potential cause of sensorineural hearing loss inelderly-AmyloDEAFNESS pilot study.
    Béquignon E; Guellich A; Bartier S; Raynal M; Prulière-Escabasse V; Canouï-Poitrine F; Coste A; Damy T
    Amyloid; 2017 Jun; 24(2):96-100. PubMed ID: 28598686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharyngo-laryngeal involvement in systemic amyloidosis with cardiac involvement: a prospective observational study.
    Bartier S; Bodez D; Kharoubi M; Canouï-Poitrine F; Chatelin V; Henrion C; Coste A; Damy T; Béquignon E
    Amyloid; 2019 Dec; 26(4):216-224. PubMed ID: 31364411
    [No Abstract]   [Full Text] [Related]  

  • 33. Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis.
    Aimo A; Rapezzi C; Perfetto F; Cappelli F; Palladini G; Obici L; Merlini G; Di Bella G; Serenelli M; Zampieri M; Milani P; Licordari R; Teresi L; Ribarich N; Castiglione V; Quattrone F; De Rosis S; Vergaro G; Panichella G; Emdin M; Passino C
    Eur J Clin Invest; 2021 Nov; 51(11):e13598. PubMed ID: 33982288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR).
    Phull P; Sanchorawala V; Connors LH; Doros G; Ruberg FL; Berk JL; Sarosiek S
    Amyloid; 2018 Mar; 25(1):62-67. PubMed ID: 29424556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-invasive detection and differentiation of cardiac amyloidosis using
    Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y
    Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma neurofilament light chain: an early biomarker for hereditary ATTR amyloid polyneuropathy.
    Maia LF; Maceski A; Conceição I; Obici L; Magalhães R; Cortese A; Leppert D; Merlini G; Kuhle J; Saraiva MJ
    Amyloid; 2020 Jun; 27(2):97-102. PubMed ID: 31906707
    [No Abstract]   [Full Text] [Related]  

  • 37. Reduced trans-mitral A-wave velocity predicts the presence of wild-type transthyretin amyloidosis in elderly patients with left ventricular hypertrophy.
    Yamamura S; Izumiya Y; Ishida T; Onoue Y; Kimura Y; Hanatani S; Araki S; Fujisue K; Sueta D; Kanazawa H; Takashio S; Usuku H; Sugamura K; Sakamoto K; Yamamoto E; Yamamuro M; Yasuda H; Kojima S; Kaikita K; Hokimoto S; Ogawa H; Tsujita K
    Heart Vessels; 2017 Jun; 32(6):708-713. PubMed ID: 27882404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular Volume Detects Amyloidotic Cardiomyopathy and Correlates With Neurological Impairment in Transthyretin-familial Amyloidosis.
    Gallego-Delgado M; González-López E; Muñoz-Beamud F; Buades J; Galán L; Muñoz-Blanco JL; Sánchez-González J; Ibáñez B; Mirelis JG; García-Pavía P
    Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):923-930. PubMed ID: 27291669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System.
    Grogan M; Scott CG; Kyle RA; Zeldenrust SR; Gertz MA; Lin G; Klarich KW; Miller WL; Maleszewski JJ; Dispenzieri A
    J Am Coll Cardiol; 2016 Sep; 68(10):1014-20. PubMed ID: 27585505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determining patterns of vascular function and structure in wild-type transthyretin cardiac amyloidosis. A comparative study.
    Stamatelopoulos K; Delialis D; Georgiopoulos G; Tselegkidi MI; Theodorakakou F; Dialoupi I; Bambatsias D; Petropoulos I; Vergaro G; Ikonomidis I; Tzortzis S; Briasoulis A; Kanakakis J; Trougakos I; Dimopoulos MA; Kastritis E
    Int J Cardiol; 2022 Sep; 363():102-110. PubMed ID: 35716935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.